Exploring the Histone Acetylation Cycle in the Protozoan Model Tetrahymena thermophila

Frontiers in Cell and Developmental Biology
Suzanne WahabJeffrey Fillingham

Abstract

The eukaryotic histone acetylation cycle is composed of three classes of proteins, histone acetyltransferases (HATs) that add acetyl groups to lysine amino acids, bromodomain (BRD) containing proteins that are one of the most characterized of several protein domains that recognize acetyl-lysine (Kac) and effect downstream function, and histone deacetylases (HDACs) that catalyze the reverse reaction. Dysfunction of selected proteins of these three classes is associated with human disease such as cancer. Additionally, the HATs, BRDs, and HDACs of fungi and parasitic protozoa present potential drug targets. Despite their importance, the function and mechanisms of HATs, BRDs, and HDACs and how they relate to chromatin remodeling (CR) remain incompletely understood. Tetrahymena thermophila (Tt) provides a highly tractable single-celled free-living protozoan model for studying histone acetylation, featuring a massively acetylated somatic genome, a property that was exploited in the identification of the first nuclear/type A HAT Gcn5 in the 1990s. Since then, Tetrahymena remains an under-explored model for the molecular analysis of HATs, BRDs, and HDACs. Studies of HATs, BRDs, and HDACs in Tetrahymena have the potential to reveal the ...Continue Reading

References

Oct 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·C D AllisM A Gorovsky
Nov 1, 1985·The Journal of protozoology·D W MartindaleP J Bruns
Dec 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·C D AllisI G Schulman
Jul 1, 1982·Experimental Cell Research·D W MartindaleP J Bruns
Jun 23, 1981·Biochemistry·C D Allis, M A Gorovsky
Jul 3, 1995·Proceedings of the National Academy of Sciences of the United States of America·J E Brownell, C D Allis
Feb 14, 1995·Proceedings of the National Academy of Sciences of the United States of America·R E SobelC D Allis
Jan 25, 1994·Nucleic Acids Research·T H ThatcherM A Gorovsky
Jun 24, 1998·Proceedings of the National Academy of Sciences of the United States of America·Y WeiC D Allis
Oct 22, 1998·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·M H Kuo, C D Allis
Feb 18, 1999·Molecular and Cellular Biology·R OhbaC D Allis
Feb 20, 1999·The Journal of Biological Chemistry·P A GrantJ L Workman
Jun 30, 2001·Molecular Cell·Q Ren, M A Gorovsky
Mar 31, 2004·Journal of Molecular Biology·Ivan V GregorettiHolly V Goodson
Jun 16, 2004·Current Opinion in Genetics & Development·Yannick Doyon, Jacques Côté
Jul 13, 2004·Cancer Treatment Reviews·Raz SomechAmos J Simon
Oct 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christopher A FrenchJonathan A Fletcher
Nov 17, 2004·Genes & Development·Peter W LewisMichael R Botchan

❮ Previous
Next ❯

Methods Mentioned

BETA
acetylation
Histone Acetylation
RNA-Seq
acetylates
ChIP-Seq

Software Mentioned

SMART
BoxShade
BLASTP
Clustal Omega
SAINTexpress

Related Concepts

Related Feeds

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.